Published in Eur J Pediatr on March 04, 2005
Varicella vaccination in Europe - taking the practical approach. BMC Med (2009) 1.63
Varicella paediatric hospitalisations in Belgium: a 1-year national survey. Arch Dis Child (2015) 1.39
Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child (2007) 1.21
Beyond counting cases: public health impacts of national Paediatric Surveillance Units. Arch Dis Child (2006) 1.17
Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands. BMC Infect Dis (2012) 1.01
The epidemiology and economic impact of varicella-related hospitalizations in Turkey from 2008 to 2010: a nationwide survey during the pre-vaccine era (VARICOMP study). Eur J Pediatr (2011) 0.92
Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months. Eur J Pediatr (2010) 0.88
Successes and challenges in varicella vaccine. Ther Adv Vaccines (2014) 0.86
Secular trends of chickenpox among military population in Israel in relation to introduction of varicella zoster vaccine 1979-2010. Hum Vaccin Immunother (2013) 0.86
Acute cerebellitis in varicella: a ten year case series and systematic review of the literature. Ital J Pediatr (2014) 0.84
Toxin profiling of Staphylococcus aureus strains involved in varicella superinfection. J Clin Microbiol (2010) 0.83
Varicella Skin Complications in Childhood: A Case Series and a Systematic Review of the Literature. Int J Mol Sci (2016) 0.78
First reported cluster of overwhelming group A streptococcal septicaemia and associated chickenpox infection in the UK. BMJ Case Rep (2009) 0.77
Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect Dis (2017) 0.75
Has VZV epidemiology changed in Italy? Results of a seroprevalence study. Hum Vaccin Immunother (2016) 0.75
Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression. Pediatr Rheumatol Online J (2016) 0.75
Economic burden of varicella in children 1-12 Years of age in Hungary, 2011-2015. BMC Infect Dis (2017) 0.75
Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev (1995) 5.71
Cost-effectiveness of a routine varicella vaccination program for US children. JAMA (1994) 3.27
The epidemiology of varicella and its complications. J Infect Dis (1995) 2.10
Population-based studies of varicella complications. Pediatrics (1986) 1.90
Age-specific risks of varicella complications. Pediatrics (1981) 1.76
Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics (2001) 1.67
Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J (2002) 1.63
Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis (1985) 1.39
The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or an associated complication. Pediatr Infect Dis J (2000) 1.27
Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J (1992) 1.26
Childhood vaccination against chickenpox: an analysis of benefits and costs. J Pediatr (1994) 1.17
Community impact of childhood varicella infections. J Pediatr (1997) 1.08
Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. J Infect Dis (2000) 1.06
Complications of varicella in a defined central European population. Arch Dis Child (1998) 1.01
Placental transfer and decay of varicella-zoster virus antibodies in preterm infants. J Pediatr (2000) 1.01
Children hospitalized for varicella: a prevaccine review. J Pediatr (1996) 0.99
The cost-effectiveness of routine childhood varicella vaccination in Germany. Vaccine (2003) 0.96
Chickenpox complications among immunocompetent hospitalized children in Italy. Acyclovir-Chickenpox Italian Study Group. Pediatr Med Chir (1997) 0.91
Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data. Vaccine (2001) 0.90
Epidemiology of primary varicella hospitalizations in Spain. Vaccine (2001) 0.85
Acute encephalitis in Swiss children: aetiology and outcome. Eur J Paediatr Neurol (1998) 0.76
Varicella zoster virus infection complicated by Neisseria meningitidis bacteraemia in two children. Eur J Pediatr (2001) 0.75
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med (2008) 3.85
Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) (2010) 2.33
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med (2003) 2.19
The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury. Immunity (2012) 2.17
Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J (2005) 2.06
Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine (2010) 1.99
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J (2006) 1.94
Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol (2010) 1.81
Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis (2011) 1.74
Ultraviolet radiation damages self noncoding RNA and is detected by TLR3. Nat Med (2012) 1.68
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine (2007) 1.66
Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases. Eur J Pediatr (2009) 1.59
Viral etiology of acute respiratory infections with cough in infancy: a community-based birth cohort study. Pediatr Infect Dis J (2008) 1.57
Real-time quantitative broad-range PCR assay for detection of the 16S rRNA gene followed by sequencing for species identification. J Clin Microbiol (2006) 1.49
Three-year surveillance of intussusception in children in Switzerland. Pediatrics (2007) 1.45
The diagnosis of brain tuberculoma by (1)H-magnetic resonance spectroscopy. Eur J Pediatr (2011) 1.39
Correlation between bacteriologic eradication and clinical cure in acute otitis media. Pediatr Infect Dis J (2004) 1.39
Influenza vaccination among healthcare workers in a university children's hospital. Infect Control Hosp Epidemiol (2005) 1.32
New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin Infect Dis (2004) 1.29
Prevalence of enteroaggregative Escherichia coli among children with and without diarrhea in Switzerland. J Clin Microbiol (2003) 1.28
Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr Allergy Immunol (2011) 1.25
Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production. Immunology (2009) 1.23
Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J (2012) 1.19
Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART. J Med Virol (2006) 1.19
The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance. Infect Immun (2005) 1.16
Infective endocarditis in congenital heart disease. Eur J Pediatr (2011) 1.15
Mycobacterium bohemicum cervical lymphadenitis. Pediatr Infect Dis J (2002) 1.15
Adaptation of the ultrasensitive HIV-1 p24 antigen assay to dried blood spot testing. J Acquir Immune Defic Syndr (2007) 1.14
Three consecutive outbreaks of Serratia marcescens in a neonatal intensive care unit. Clin Infect Dis (2002) 1.13
How do physicians immunize their own children? Differences among pediatricians and nonpediatricians. Pediatrics (2005) 1.13
Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age. Vaccine (2006) 1.12
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013. Pediatr Infect Dis J (2015) 1.12
The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Vaccine (2002) 1.11
Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease. Infect Immun (2005) 1.10
Is the in vitro interferon-gamma release assay an adequate replacement for the tuberculin skin test? Clin Infect Dis (2002) 1.10
The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children. Vaccine (2002) 1.10
Standardised case definitions for adverse events following immunisation. Lancet (2013) 1.09
Addressing the needs and gaps in safety assessment of vaccines during clinical trials in resource limited countries. Vaccine (2011) 1.09
Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection. Pediatr Infect Dis J (2004) 1.09
Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children. Pediatr Infect Dis J (2003) 1.08
Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol (2003) 1.07
Sex and gender differences in travel-associated disease. Clin Infect Dis (2010) 1.05
The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children? Clin Infect Dis (2002) 1.04
Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR. J Clin Microbiol (2003) 1.04
Intussusception: incidence and treatment-insights from the nationwide German surveillance. J Pediatr Gastroenterol Nutr (2011) 1.03
Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine (2011) 1.02
Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults. Infect Immun (2003) 1.01
Physiologic cold shock increases adherence of Moraxella catarrhalis to and secretion of interleukin 8 in human upper respiratory tract epithelial cells. J Infect Dis (2009) 1.01
Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray. Virol J (2006) 1.00
Inadequate clearance of translocated bacterial products in HIV-infected humanized mice. PLoS Pathog (2010) 1.00
Profile of travel-associated illness in children, Zürich, Switzerland. J Travel Med (2012) 0.99
Health burden of pertussis in infants and children. Pediatr Infect Dis J (2005) 0.99
A reservoir of Moraxella catarrhalis in human pharyngeal lymphoid tissue. J Infect Dis (2007) 0.99
Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis. Clin Infect Dis (2010) 0.98
Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease. Infect Immun (2005) 0.98
Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma. AIDS (2009) 0.98
Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients. Pediatr Infect Dis J (2007) 0.97
Distinct ex vivo susceptibility of B-cell subsets to epstein-barr virus infection according to differentiation status and tissue origin. J Virol (2008) 0.97
Cold shock response of the UspA1 outer membrane adhesin of Moraxella catarrhalis. Infect Immun (2005) 0.95
All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunization. Vaccine (2007) 0.95
Outer membrane protein UspA1 and lipooligosaccharide are involved in invasion of human epithelial cells by Moraxella catarrhalis. Microbes Infect (2007) 0.95
Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J (2004) 0.95
A distinct subpopulation of human NK cells restricts B cell transformation by EBV. J Immunol (2013) 0.95
Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine (2007) 0.94
Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis. Clin Infect Dis (2004) 0.94
Voriconazole-induced phototoxicity in children. Pediatr Infect Dis J (2012) 0.94
Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies. Vaccine (2008) 0.94
Neonatal and pediatric antimicrobial stewardship programs in Europe-defining the research agenda. Pediatr Infect Dis J (2013) 0.93
Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis. Clin Vaccine Immunol (2010) 0.93
Comparison of clinical characteristics of influenza and respiratory syncytial virus infection in hospitalised children and adolescents. Eur J Pediatr (2004) 0.93
Seroprevalence and immunization history of selected vaccine preventable diseases in medical students. Vaccine (2005) 0.93
Immune activation suppresses initiation of lytic Epstein-Barr virus infection. Cell Microbiol (2007) 0.93
Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns. Pediatr Infect Dis J (2004) 0.92
Quantitative cytokine gene expression in human tonsils at excision and during histoculture assessed by standardized and calibrated real-time PCR and novel data processing. J Immunol Methods (2003) 0.92
Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia. Arch Pediatr Adolesc Med (2002) 0.92
HIV-1 does not provoke alteration of cytokine gene expression in lymphoid tissue after acute infection ex vivo. J Immunol (2004) 0.92
Prospective pertussis surveillance in Switzerland, 1991-2006. Vaccine (2011) 0.91
Detection of Haemophilus influenzae type b by real-time PCR. J Clin Microbiol (2004) 0.91
Comparative coverage of supplementary and universally recommended immunizations in children at 24 months of age. Pediatr Infect Dis J (2012) 0.91
Congenital H-ficolin deficiency in premature infants with severe necrotising enterocolitis. Gut (2010) 0.90
The parental appraisal of the morbidity of diarrhea in infants and toddlers (PAMODI) survey. Clin Pediatr (Phila) (2008) 0.90
No temporal association between influenza outbreaks and invasive pneumococcal infections. Arch Dis Child (2007) 0.90
Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis. FEMS Immunol Med Microbiol (2006) 0.90
Diffusion tensor imaging in progressive multifocal leukoencephalopathy: early predictor for demyelination? AJNR Am J Neuroradiol (2005) 0.90
Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur J Pediatr (2002) 0.90
Pediatric epstein-barr virus carriers with or without tonsillar enlargement may substantially contribute to spreading of the virus. J Infect Dis (2010) 0.90
Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritis. Eur J Pediatr (2007) 0.90
Twelve years' detection of respiratory viruses by immunofluorescence in hospitalised children: impact of the introduction of a new respiratory picornavirus assay. BMC Infect Dis (2011) 0.90
Mansonella perstans causing symptomatic hypereosinophilia in a missionary family. Travel Med Infect Dis (2005) 0.89
A 4-year study on clinical characteristics of children hospitalized with rotavirus gastroenteritis. Eur J Pediatr (2009) 0.89